Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Advances in Experimental Medicine and Biology
|
April 30, 2009
Portraits of the pioneers of the American Peptide Society
Carine B Bourguet, Aurélie Dörr, Tanya Godina, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
January 25, 2017
Design, synthesis and antimalarial activity of novel bis{N-[(pyrrolo[1,2-a]quinoxalin-4-yl)benzyl]-3-aminopropyl}amine derivatives
Jean Guillon, Anita Cohen, Nassima Meriem Gueddouda, et al.
European Journal of Medicinal Chemistry
|
May 27, 2014
Design, synthesis and biological evaluation of novel 4-alkapolyenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents--part III
Luisa Ronga, Marco Del Favero, Anita Cohen, et al.
Chemmedchem
|
December 6, 2016
Design, Synthesis, and Evaluation of 2,9-Bis[(substituted-aminomethyl)phenyl]-1,10-phenanthroline Derivatives as G-Quadruplex Ligands
Nassima Meriem Gueddouda, Miyanou Rosales Hurtado, Stéphane Moreau, et al.
European Journal of Medicinal Chemistry
|
May 6, 2025
Design, synthesis, biophysical and biological evaluation of original condensed pyrrolopyrimidine and pyrrolopyridine ligands as anti-SARS-CoV-2 agents targeting G4
Jean Guillon, Solène Savrimoutou, Nicolas Da Rocha, et al.
Chemical Biology & Drug Design
|
December 22, 2017
Design, synthesis, and antiprotozoal evaluation of new 2,9-bis[(substituted-aminomethyl)phenyl]-1,10-phenanthroline derivatives
Jean Guillon, Anita Cohen, Rabindra Nath Das, et al.
Archiv Der Pharmazie
|
April 14, 2021
Design, synthesis, and antiproliferative effect of 2,9-bis[4-(pyridinylalkylaminomethyl)phenyl]-1,10-phenanthroline derivatives on human leukemic cells by targeting G-quadruplex
Jean Guillon, Caroline Denevault-Sabourin, Edith Chevret, et al.
Pathogens (Basel, Switzerland)
|
November 24, 2022
Design, Synthesis, and Antiprotozoal Evaluation of New Promising 2,9-<i>Bis</i>[(substituted-aminomethyl)]-4,7-phenyl-1,10-phenanthroline Derivatives, a Potential Alternative Scaffold to Drug Efflux
Jean Guillon, Anita Cohen, Clotilde Boudot, et al.
Pharmaceuticals (Basel, Switzerland)
|
January 23, 2024
New 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinazoline and 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinoline Derivatives: Synthesis and Biological Evaluation as Novel Anticancer Agents by Targeting G-Quadruplex
Jean Guillon, Marc Le Borgne, Vittoria Milano, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
January 5, 2020
Design, synthesis, and antiprotozoal evaluation of new 2,4-bis[(substituted-aminomethyl)phenyl]quinoline, 1,3-bis[(substituted-aminomethyl)phenyl]isoquinoline and 2,4-bis[(substituted-aminomethyl)phenyl]quinazoline derivatives
Jean Guillon, Anita Cohen, Clotilde Boudot, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Advances in Experimental Medicine and Biology
|
April 30, 2009
Portraits of the pioneers of the American Peptide Society
Carine B Bourguet, Aurélie Dörr, Tanya Godina, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
January 25, 2017
Design, synthesis and antimalarial activity of novel bis{N-[(pyrrolo[1,2-a]quinoxalin-4-yl)benzyl]-3-aminopropyl}amine derivatives
Jean Guillon, Anita Cohen, Nassima Meriem Gueddouda, et al.
European Journal of Medicinal Chemistry
|
May 27, 2014
Design, synthesis and biological evaluation of novel 4-alkapolyenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents--part III
Luisa Ronga, Marco Del Favero, Anita Cohen, et al.
Chemmedchem
|
December 6, 2016
Design, Synthesis, and Evaluation of 2,9-Bis[(substituted-aminomethyl)phenyl]-1,10-phenanthroline Derivatives as G-Quadruplex Ligands
Nassima Meriem Gueddouda, Miyanou Rosales Hurtado, Stéphane Moreau, et al.
European Journal of Medicinal Chemistry
|
May 6, 2025
Design, synthesis, biophysical and biological evaluation of original condensed pyrrolopyrimidine and pyrrolopyridine ligands as anti-SARS-CoV-2 agents targeting G4
Jean Guillon, Solène Savrimoutou, Nicolas Da Rocha, et al.
Chemical Biology & Drug Design
|
December 22, 2017
Design, synthesis, and antiprotozoal evaluation of new 2,9-bis[(substituted-aminomethyl)phenyl]-1,10-phenanthroline derivatives
Jean Guillon, Anita Cohen, Rabindra Nath Das, et al.
Archiv Der Pharmazie
|
April 14, 2021
Design, synthesis, and antiproliferative effect of 2,9-bis[4-(pyridinylalkylaminomethyl)phenyl]-1,10-phenanthroline derivatives on human leukemic cells by targeting G-quadruplex
Jean Guillon, Caroline Denevault-Sabourin, Edith Chevret, et al.
Pathogens (Basel, Switzerland)
|
November 24, 2022
Design, Synthesis, and Antiprotozoal Evaluation of New Promising 2,9-<i>Bis</i>[(substituted-aminomethyl)]-4,7-phenyl-1,10-phenanthroline Derivatives, a Potential Alternative Scaffold to Drug Efflux
Jean Guillon, Anita Cohen, Clotilde Boudot, et al.
Pharmaceuticals (Basel, Switzerland)
|
January 23, 2024
New 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinazoline and 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinoline Derivatives: Synthesis and Biological Evaluation as Novel Anticancer Agents by Targeting G-Quadruplex
Jean Guillon, Marc Le Borgne, Vittoria Milano, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
January 5, 2020
Design, synthesis, and antiprotozoal evaluation of new 2,4-bis[(substituted-aminomethyl)phenyl]quinoline, 1,3-bis[(substituted-aminomethyl)phenyl]isoquinoline and 2,4-bis[(substituted-aminomethyl)phenyl]quinazoline derivatives
Jean Guillon, Anita Cohen, Clotilde Boudot, et al.
Page
of 6